Related Experiment Videos
Oesophageal atresia
1Queen Elizabeth Hospital for Children, London.
British Journal of Hospital Medicine
|December 1, 1989
Insights
Congenital esophageal atresia, once fatal, is now treatable due to medical advances. Survival is high, with deaths mainly linked to prematurity or other major birth defects.
Area of Science:
- Pediatric Surgery
- Neonatology
- Medical Technology
Background:
- Esophageal atresia (EA) was historically a fatal congenital anomaly.
- Significant advancements in medical care have transformed outcomes for affected infants.
Purpose of the Study:
- To review the current survival rates and causes of mortality in patients with esophageal atresia.
- To highlight the impact of modern neonatal intensive care, anesthesia, and surgical techniques on patient outcomes.
Main Methods:
- Review of historical and contemporary patient data.
- Analysis of survival trends and mortality causes in esophageal atresia cases.
- Assessment of the role of neonatal intensive care, anesthesia, and surgical interventions.
Main Results:
- Successful correction of esophageal atresia is now achievable in most patients.
- Mortality is rarely due to esophageal atresia itself.
- Deaths are predominantly observed in extremely premature infants and those with significant co-occurring anomalies.
Conclusions:
- Modern medical and surgical interventions have drastically improved survival for esophageal atresia.
- Focus for improving outcomes should extend to managing prematurity and associated anomalies.
Abstract:
Fifty years ago this congenital anomaly was incompatible with survival. Advances in neonatal intensive care, anaesthesia and surgical techniques permit successful correction in the vast majority of patients. Death in a patient with oesophageal atresia is now rarely attributable to that anomaly, but occurs in the very premature and those babies with other associated major anomalies.